back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 17:35 Tx date 2026-06-02 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$1,260,000 vol |
$1,260,000 | |
| Filed 2026-06-04 17:26 Tx date 2026-06-02 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,260 vol $1,000 each |
||
| Filed 2026-06-04 17:21 Tx date 2019-08-21 |
$HBP
Helix BioPharma Corp. |
Wilczewski, Jerzy
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-26 11:25 Tx date 2025-06-02 |
$HBP
Helix BioPharma Corp. |
Babbar, Rohit
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-26 11:25 Tx date 2025-06-02 |
$HBP
Helix BioPharma Corp. |
Babbar, Rohit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-26 10:08 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Babbar, Rohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2026-05-26 10:07 Tx date 2025-06-02 |
$HBP
Helix BioPharma Corp. |
Babbar, Rohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-25 16:07 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Butterworth, Natalia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
30,000 | |
| Filed 2026-05-25 16:07 Tx date 2026-05-13 |
$HBP
Helix BioPharma Corp. |
Butterworth, Natalia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-25 16:04 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Guggi, Davide
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+190,000 vol |
190,000 | |
| Filed 2026-05-25 16:04 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Guggi, Davide
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-25 15:57 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Kandziora, Veronika Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+380,000 vol |
380,000 | |
| Filed 2026-05-25 15:57 Tx date 2025-03-01 |
$HBP
Helix BioPharma Corp. |
Kandziora, Veronika Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-25 15:55 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2026-05-25 15:54 Tx date 2026-05-13 |
$HBP
Helix BioPharma Corp. |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-25 15:52 Tx date 2026-05-21 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+180,000 vol |
380,000 | |
| Filed 2026-05-25 15:50 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2025-07-29 14:30 Tx date 2025-07-21 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,170
+17,000 vol $1.01 each |
47,000 | |
| Filed 2025-07-29 14:29 Tx date 2025-07-17 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,700
+30,000 vol $0.99 each |
30,000 | |
| Filed 2025-07-29 14:24 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|